Prevalence of helicobacter pylori and occurrence of gastroduodenal lesions in patients with liver cirrhosis

International Journal of Clinical and Experimental Medicine

Volumn 4, Issue 1, 2011, Pages 26-31

  Kirchner, Gabriele I ^a,b   Beil, Winfried ^a   Bleck, Joerg S ^a   Manns, Micheal P ^a   Wagner, Siegfried ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Gastroduodenal ulcers; Helicobacter pylori; Hepatitis; Liver cirrhosis

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ADULT; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM DETECTION; CHRONIC HEPATITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DUODENUM DISEASE; FEMALE; GASTRODUODENAL EROSION; GASTRODUODENAL ULCER; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PEPTIC ULCER; SEROPREVALENCE; STOMACH EROSION; STOMACH MUCOSA; SYMPTOM; VIRUS HEPATITIS;

HELICOBACTER PYLORI;

EID: 79951686126     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002;347:1175-1186.
2. Cover TL, Blaser MJ. H. pylori in health and disease. Gastroenterology 2009;136:1863-873.
3. Wagner S, Beil W, Westermann J, et al Regulation of gastric epithelial cell growth by Helicobacter pylori: evidence for a major role of apoptosis. Gastroenterology 1997;113:1836-1847.
4. Saadat I, Higashi H, Umeda M, et al Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature 2007;447:330-333.
5. Chen LS, Lin HC, Hwang SJ, Lee FY, Hou MC, Lee SD. Prevalence of gastric ulcer in cirrhotic patients and its relation to portal hypertension. J Gastroenterol Hepatol 1996;11:59-64.
6. Siringo S, Burroughs AK, Bolondi L, et al Peptic ulcer and its course in cirrhosis: an endoscopic and clinical prospective study. J Hepatol 1995; 22: 633-641.
7. Tsai CJ. Helicobacter pylori infection and peptic ulcer disease in cirrhosis. Dig Dis Sci 1998;43:1219-25.
8. Vergara M, Calvet X, Roque M. Helicobacter pylori is a risk factor for peptic ulcer disease in cirrhotic patients. A meta.analysis. Eur J Gastroenterol Hepatol 2002;14:717-722.
9. Lo GH, Yu HC, Chan YC, et al The effects of eradication of Helicobacter pylori on the recurrence of duodenal ulcers in patients with cirrhosis. Gastrointest Endosc 2005;62:350-356.
10. Seckin Y, Harputluoglu MMM, Batcioglu K, et al Gastric tissue oxidative changes in portal hyper tension and cirrhosis. Dig Dis Sci 2007;52:1154-1158.
11. Rabinovitz M, Yoo Y-K, Schade RR, Dindzans VJ, Van Thiel DH, Gavaler JS. Prevalence of endoscopic findings in 510 consecutive individuals with liver cirrhosis evaluated prospectively Dig Dis Sci 1990; 35: 705-10.
12. Siringo S, Vaira D, Menegatti M, et al High prevalence of Helicobacter pylori in liver cirrhosis: relationship with clinical and endoscopic features and the risk of peptic ulcer. Dig Dis Sci 1997;42:2024-2030.
13. Wu CS, Lin CY, Liaw YF. Helicobacter pylori in cirrhotic patients with peptic ulcer disease: a prospective, case controlled study. Gastrointest Endosc 1995;42:424-427.
14. Villalan R, Maroju NK, Kate V, Ananthakrishnan N. Is Helicobacter pylori eradication indicated in cirrhotic patients with peptic ulcer disease? Trop Gastroenterol 2006;27:166-8.
15. Tzathas C, Triantafyllou K, Mallas E, Triantafyllou G, Ladas SD. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study. J Clin Gastroenterol 2008;42-744-749.
16. Chen JJ, Changchien CS, Tai DI, Chiou SS, Lee CM, Kuo CH. Role of Helicobacter pylori in cirrhotic patients with peptic ulcer. Dig Dis Sci 1994; 39: 1565-1568.
17. Calvet X, Navarro M, Gil M, et al Seroprevalence and epidemiology of Helicobacter pylori infection in patients with cirrhosis. J Hepatol 1997;26:1249-54.
18. Pellicano R, Leone N, Berrutti M, et al Helicobacter pylori seroprevalence in hepatitis C virus positive patients with cirrhosis. J Hepatol 2000;33:648-50.
19. Auroux J, Lamarque D, Roudot-Thorabval F, et al Gastroduodenal ulcer and erosions are related to portal hypertensive gastropathy and recent alcohol intake in cirrhotic patients. Dig Dis Sci 2003;48:1118-1123.
20. McCormack TT, Sims J, Eyre-Brook I, et al Gastric lesions in portal hypertension: inflammatory gastritis or congestive gastropathy? Gut 1985;26:1226-1232.
21. Paquet KJ. Prophylactic endoscopic sclerosing treatment of the esophageal wall in varices - a prospective controlled randomised trail. Endoscopy 1982;14:4-5.
22. Martin JH, Potthoff A, Ledig S, et al Effect of h. pylori on the expression of TRAIL, FasL and their receptor subtypes in human gastric epithelial cells and their role in apoptosis. Helicobacter 2004;9:371-386.
23. Hui WM, Lam SK, Chau PY, et al Persistence of Campylobacter pyloridis despite healing of duodenal ulcer and improvement of accompanying duodenitis and gastritis. Dig Dis Sci 1987;32: 1255-1260.
24. Nardone G, Coscione P, DArmiento FP, et al Cirrhosis negatively affects the efficiency of serologic diagnosis of Helicobacter pylori infection. Ital J Gastroenterol 1996;28:332-336.
25. Jung SW, Lee SW, Hyun JJ, et al Efficacy of Helicobacter pylori eradication therapy in chronic liver disease. Dig Liver Disease 2009;41:134-140.
26. Arakawa T, Satoh H, Fukada T, Nakamura H, Kobayashi K. Endogenous prostaglandin E2 in gastric mucosa of patients with alcoholic cirrhosis and portal hypertension. Gastroenterology 1987;93:135-140.
27. Samloff IM. Multiple gastric red spots, capillary ectasia, hypergastrinemia and hypopepsinogenemia I in cirrhosis: a new syndrome? Hepatology 1988;8:699-700.
28. Guslandi M, Foppa L, Sorghi M, Pellegrini A, Fanti L, Tittobello A. Breakdown of mucosal defences in congestive gastropathy in cirrhotics. Liver 1992;12:303-305.
29. Balan KK, Jones AT, Roberts NB, Pearson JP, Critchley M, Jenkins SA. The effects of Helicobacter pylori colonization on gastric function and the incidence of portal hypertensive gastropathy in patients with cirrhosis of the liver. Am J Gastroenterol 1996;91:1400-1406.
30. Perini RF, Camara PR, Ferraz JG. Pathogenesis of portal hyertensive gastropathy: translating basic research into clinical practice. Nat Clin Pract Gastroenterol Hepatol 2009;6:150-158.
31. Batmanabane V, Kate V, Ananthakrishnan N. Prevalence of Helicobacter pylori in patients with portal hypertensive gastropathy - a study from South India. Med Sci Monit 2004;10:133-136.
32. Bahnacy A, Kupcsulik P, Eles Z, Jaray B, Flautner L. Helicobacter pylori and congestive gastropathy. Z Gastroenterol 1997;35:109-112.
33. Schmulson MJ, De Leon G, Kershenovich A, Vargas-Vorackova F, Kershenobich D. Helicobacter pylori infection among patients with alcoholic and non-alcoholic cirrhosis. Helicobacter 1997;2:149-151.
34. Kim DJ, Kim HY, Kim SJ, et al Helicobacter pylori infection and peptic ulcer disease in patients with liver cirrhosis. Korean J Internal Med 2008;23:16-21.
35. Rabinovitz M, Schade RR, Dindzans VJ, Van Thiel DH, Gavaler JS. Prevalence of duodenal ulcer in cirrhotic males referred for duodenal ulcer in cirrhotic males referred for liver transplantation - does the etiology of cirrhosis make a difference? Dig Dis Sci 1990; 35: 321-326.